Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis.
Abstract | BACKGROUND: METHODS: The Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION) trial will evaluate the cardiovascular safety of celecoxib, ibuprofen, and naproxen. Approximately 20,000 patients with symptomatic osteoarthritis or rheumatoid arthritis at high risk for, or with, established cardiovascular disease will be randomized in this double-blind, triple dummy, multinational, multicenter study. The primary end point is the composite of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke. The trial will continue until 762 primary events occur with at least 18 months follow-up. Noninferiority of any of the regimens will require a 97.5% upper CI of the hazard ratio (HR) < or =1.33 and point estimate < or =1.12 for both intent-to-treat (ITT) and modified ITT populations. CONCLUSION:
|
Authors | Matthew C Becker, Thomas H Wang, Lisa Wisniewski, Kathy Wolski, Peter Libby, Thomas F Lüscher, Jeffrey S Borer, Alice M Mascette, M Elaine Husni, Daniel H Solomon, David Y Graham, Neville D Yeomans, Henry Krum, Frank Ruschitzka, A Michael Lincoff, Steven E Nissen, PRECISION Investigators |
Journal | American heart journal
(Am Heart J)
Vol. 157
Issue 4
Pg. 606-12
(Apr 2009)
ISSN: 1097-6744 [Electronic] United States |
PMID | 19332185
(Publication Type: Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)
|
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Cyclooxygenase Inhibitors
- Pyrazoles
- Sulfonamides
- Naproxen
- Celecoxib
- Ibuprofen
|
Topics |
- Anti-Inflammatory Agents, Non-Steroidal
(administration & dosage, therapeutic use)
- Arthritis
(drug therapy)
- Cardiovascular Diseases
(epidemiology, prevention & control)
- Celecoxib
- Cyclooxygenase Inhibitors
(administration & dosage, therapeutic use)
- Dose-Response Relationship, Drug
- Double-Blind Method
- Follow-Up Studies
- Humans
- Ibuprofen
(administration & dosage, therapeutic use)
- Middle Aged
- Naproxen
(administration & dosage, therapeutic use)
- Prospective Studies
- Pyrazoles
(administration & dosage, therapeutic use)
- Sulfonamides
(administration & dosage, therapeutic use)
- Treatment Outcome
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|